The MNS16A VNTR polymorphism of the TERT gene in bladder cancer
Yıl: 2020 Cilt: 46 Sayı: 1 Sayfa Aralığı: 44 - 49 Metin Dili: İngilizce DOI: 10.5152/tud.2019.19005 İndeks Tarihi: 16-10-2020
The MNS16A VNTR polymorphism of the TERT gene in bladder cancer
Öz: Objective: Bladder cancer (BC) is a complex disease that has a high morbidity rate. The MNS16A poly-morphism in the TERT gene has been indicated to play a role in the presence of various cancer types and multiple tumor populations. In the present study, our goal was to investigate whether the MNS16A (VNTRs) in the TERT gene was associated with bladder cancer.Material and methods: A total of 70 patients with BC and 120 normal controls were included in the study. The MNS16A (VNTRs) in the TERT gene was amplified using polymerase chain reaction (PCR). The PCR products were visualized on 3% high resolution agarose gel and under a UV light.Results: The MNS16A VNTR-302 allele was found to be the most common allele in both, the patient group (64%) and the control group (62%). The second most common allele was the VNTR-243 allele that occurred at a frequency of around 34% in BC patients and 33% in the controls. VNTR-333 (patient group, 1%; control group, 3%) and VNTR-274 (patient group, 2%; control group, 1%) alleles were reported as the least common alleles in this study.Conclusion: When comparing the frequencies of genetic variants between cases and controls, we observed that our findings did not support the hypothesis that the MNS16A VNTR polymorphism of the TERT gene might regulate cancer susceptibility.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Sanli O, Dobruch J, Knowles MA. Bladder cancer. Nat Rev Dis Primers 2017;3:17022. [CrossRef]
- 2. Moon I, Jarstfer M. The human telomere and its relationship to human disease, therapy, and tissue engineering. Front Biosci 2007;12:4595-620. [CrossRef]
- 3. Mirabello L, Yu K, Kraft P, De Vivo I, Hunter DJ, Prescott J, et al. The association of telomere length and genetic variation in telo-mere biology genes. Hum Mutat 2010;31:1050-8. [CrossRef]
- 4. Iizuka T, Sawabe M, Takubo K, Liu M, Homma Y, Suzuki M, et al. hTERT promoter polymorphism,-1327C> T, is associated with the risk of epithelial cancer. Springerplus 2013;2:249. [CrossRef]
- 5. Zhang Y, Zhang H, Zhai Y, Wang Z, Ma F, Wang H, et al. A func-tional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population. BMC Med 2011;9:106. [CrossRef]
- 6. Hofer P, Baierl A, Feik E, Führlinger G, Leeb G, Mach K, et al. MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer. Carcinogenesis 2011;32:866-71. [CrossRef]
- 7. Liu L, Wang C, Lu X, Xiao F, Wang H, Yang L, et al. The MNS16A polymorphism in the TERT gene in peri-centenarians from the Han Chinese population. Sci China Life Sci 2014;57:1024-7. [CrossRef]
- 8. Baird D. Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med 2010;12:E16. [CrossRef]
- 9. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a suscepti-bility locus for lung cancer at 15q25. 1. Nat Genet 2008;40:616-22. [CrossRef]
- 10. Pande M, Spitz MR, Wu X, Gorlov IP, Chen WV, Amos CI. Novel genetic variants in the chromosome 5p15. 33 region associate with lung cancer risk. Carcinogenesis 2011;32:1493-9. [CrossRef]
- 11. Engelhardt M, Albanell J, Drullinsky P, Han W, Guillem J, Scher HI, et al. Relative contribution of normal and neoplastic cells deter-mines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Clin Cancer Res 1997;3:1849-57.
- 12. De Leon AD, Cronkhite JT, Katzenstein ALA, Godwin JD, Raghu G, Glazer CS, et al. Telomere lengths, pulmonary fibrosis and telom-erase (TERT) mutations. PloS One 2010;5:e10680. [CrossRef]
- 13. Jin G, Xu L, Shu Y, Tian T, Liang J, Xu Y, et al. Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis 2009;30:987-90. [CrossRef]
- 14. Petersen G, Amundadottir L, Fuchs C, Kraft P, Stolzenberg-Solo-mon R, Jacobs K, et al. A genome-wide association study identi-fies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Gen 2010;42:224-8. [CrossRef]
- 15. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-6. [CrossRef]
- 16. Landi M, Chatterjee N, Yu K, Goldin L, Goldstein A, Rotunno M, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarci-noma. Am J Hum Genet 2009;85:679-91. [CrossRef]
- 17. Jin G, Yoo SS, Cho S, Jeon HS, Lee WK, Kang HG, et al. Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer. Cancer Sci 2011;102:144-9. [CrossRef]
- 18. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malm-er B, et al. Genome-wide association study identifies five suscepti-bility loci for glioma. Nat Genet 2009;41:899-904. [CrossRef]
- 19. Wrensch M, Jenkins R, Chang J, Yeh R, Xiao Y, Decker P, et al. Vari-ants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009;41:905-8. [CrossRef]
- 20. Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, Ryk C, et al. TERT promoter mutations in bladder cancer af-fect patient survival and disease recurrence through modifica-tion by a common polymorphism. Proc Natl Acad Sci U S A 2013;110:17426-31. [CrossRef]
- 21. Giedl J, Rogler A, Wild A, Riener MO, Filbeck T, Burger M, et al. TERT core promotor mutations in early-onset bladder cancer. J Cancer 2016;7:915-20. [CrossRef]
- 22. Shadrina AS, Boyarskikh UA, Oskina NA, Sinkina TV, Laza-rev AF, Petrova VD, et al. TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population. Tumour Biol 2015;36:841-7. [CrossRef]
- 23. Wang L, Soria JC, Chang YS, Lee HY, Wei Q, Mao L. Association of a functional tandem repeats in the downstream of human telomer-ase gene and lung cancer. Oncogene 2003;22:7123-9. [CrossRef]
- 24. Hofer P, Zöchmeister C, Behm C, Brezina S, Baierl A, Doriguzzi A, et al. MNS16A tandem repeat minisatellite of human telomer-ase gene: functional studies in colorectal, lung and prostate cancer. Oncotarget 2017;8:28021-7. [CrossRef]
- 25. Wang L, Wang LE, Mao L, Spitz MR, Wei Q. A Functional Vari-ant of Tandem Repeats in Human Telomerase Gene Was Associ-ated with Survival of Patients with Early Stages of Non-Small Cell Lung Cancer. Clin Cancer Res 2010;16:3779-85. [CrossRef]
- 26. Hofer P, Zerelles J, Baierl A, Madersbacher S, Schatzl G, Maj-Hes A, et al. MNS16A tandem repeat minisatellite of human telomerase gene and prostate cancer susceptibility. Mutagenesis 2013;28:301-6. [CrossRef]
- 27. Concetti F, Lucarini N, Carpi FM, Di Pietro F, Dato S, Capitani M, et al. The functional VNTR MNS16A of the TERT gene is associ-ated with human longevity in a population of Central Italy. Exp Gerontol 2013;48:587-92. [CrossRef]
- 28. Wang Y, Hu Z, Liang J, Wang Z, Tang J, Wang S, et al. A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women. Carcinogenesis 2008;29:1197-201. [CrossRef]
- 29. Wang L, Wie Q, Wang LE, Aldape KD, Cao Y, Okcu MF, et al. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol 2006;24:1627-32. [CrossRef]
- 30. Soerensen M, Thinggaard M, Nygaard M, Dato S, Tan Q, Hjelm-borg J, et al. Genetic variation in TERT and TERC and human leukocyte telomere length and longevity: a cross-sectional and lon-gitudinal analysis. Aging Cell 2012;11:223-7. [CrossRef]
| APA | Budak Diler S, Polat F, Bingöl G (2020). The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. , 44 - 49. 10.5152/tud.2019.19005 |
| Chicago | Budak Diler Songül,Polat Fikriye,Bingöl Günsel The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. (2020): 44 - 49. 10.5152/tud.2019.19005 |
| MLA | Budak Diler Songül,Polat Fikriye,Bingöl Günsel The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. , 2020, ss.44 - 49. 10.5152/tud.2019.19005 |
| AMA | Budak Diler S,Polat F,Bingöl G The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. . 2020; 44 - 49. 10.5152/tud.2019.19005 |
| Vancouver | Budak Diler S,Polat F,Bingöl G The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. . 2020; 44 - 49. 10.5152/tud.2019.19005 |
| IEEE | Budak Diler S,Polat F,Bingöl G "The MNS16A VNTR polymorphism of the TERT gene in bladder cancer." , ss.44 - 49, 2020. 10.5152/tud.2019.19005 |
| ISNAD | Budak Diler, Songül vd. "The MNS16A VNTR polymorphism of the TERT gene in bladder cancer". (2020), 44-49. https://doi.org/10.5152/tud.2019.19005 |
| APA | Budak Diler S, Polat F, Bingöl G (2020). The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. Turkish Journal of Urology, 46(1), 44 - 49. 10.5152/tud.2019.19005 |
| Chicago | Budak Diler Songül,Polat Fikriye,Bingöl Günsel The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. Turkish Journal of Urology 46, no.1 (2020): 44 - 49. 10.5152/tud.2019.19005 |
| MLA | Budak Diler Songül,Polat Fikriye,Bingöl Günsel The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. Turkish Journal of Urology, vol.46, no.1, 2020, ss.44 - 49. 10.5152/tud.2019.19005 |
| AMA | Budak Diler S,Polat F,Bingöl G The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. Turkish Journal of Urology. 2020; 46(1): 44 - 49. 10.5152/tud.2019.19005 |
| Vancouver | Budak Diler S,Polat F,Bingöl G The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. Turkish Journal of Urology. 2020; 46(1): 44 - 49. 10.5152/tud.2019.19005 |
| IEEE | Budak Diler S,Polat F,Bingöl G "The MNS16A VNTR polymorphism of the TERT gene in bladder cancer." Turkish Journal of Urology, 46, ss.44 - 49, 2020. 10.5152/tud.2019.19005 |
| ISNAD | Budak Diler, Songül vd. "The MNS16A VNTR polymorphism of the TERT gene in bladder cancer". Turkish Journal of Urology 46/1 (2020), 44-49. https://doi.org/10.5152/tud.2019.19005 |
